laurence albigès, md, phd, on patient responses to combo nivolumab ipilimumab in 1st line rcc
Published 3 years ago • 90 plays • Length 1:54
Download video MP4
Download video MP3
Similar videos
-
1:08
laurence albigès, md, phd, shares outcomes & updates from the checkmate 214 study in advanced rcc
-
0:59
laurence albigès, md, phd, offers opinion on whether checkmate 214 is practice-changing
-
1:55
investigating responses to nivolumab and ipilimumab in advanced rcc
-
2:24
current and emerging treatment strategies for patients with mccrcc
-
2:09
tian zhang, md, on the follow up study investigating nivolumab ipilimumab in 1st line rcc patients
-
2:31
javelin renal 101: combination approach for advanced rcc patients | laurence albiges
-
8:26
front-line therapy with nivolumab and salvage nivolumab ipilimumab in patients with advanced rcc
-
7:18
who is the appropriate rcc patient to receive combination ipilimumab/nivolumab?
-
4:50
ipilimumab/nivolumab in first-line mrcc
-
4:21
biomarker development in rcc and uc
-
1:42
dr. mcdermott on immotion150 trial in rcc
-
0:39
dr. atkinson on when to use nivolumab monotherapy versus nivolumab/ipilimumab combination
-
2:01
michael atkins, md, discusses checkmate-214 investigating nivolumab ipilimumab in rcc patients
-
1:01
rana mckay, md, discusses checkmate214 investigating nivolumab ipilimumab in 1st line rcc patients
-
1:30
targeted therapies for the treatment of mrcc after nivolumab-ipilimumab failure
-
1:52
hcrn gu16-260: nivolumab and salvage nivolumab ipilimumab in treatment-naïve patients with adv...
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
1:27
dr. hammers on nivolumab/ipilimumab data in rcc
-
5:44
hcrn-gu16-260: nivolumab and salvage nivolumab-ipilimumab in patients with advanced rcc
Clip.africa.com - Privacy-policy